Cetuximab and Pembrolizumab in Treating Patients With Colorectal Cancer That is Metastatic or Cannot Be Removed by Surgery
Study Number: 

I 274515

Phase: 
Early Phase
Trial categories: 
Colorectal
Colon
Rectal
Immunotherapy
Early Phase Clinical Trial
Checkpoint blockade
Antibody therapy
Principal Investigator: